Major waste of space.
Totally. Don't people know it's 2014 and, um, there are hipsters and robots and stuff, and everyone is supposed to want to live in a studio apartment with some sleek Swedish-made cabinets to keep their children in?
Major waste of space.
Totally. Don't people know it's 2014 and, um, there are hipsters and robots and stuff, and everyone is supposed to want to live in a studio apartment with some sleek Swedish-made cabinets to keep their children in?
BBJ exclusive: Major life sciences company hunting for new U.S. headquarters in Cambridge
May 29, 2014, 2:00pm EDT
By Craig Douglas
Massachusetts economic and business officials are in the advanced stages of a clandestine plan to relocate the U.S. headquarters of a major life sciences company to Cambridge from out of state.
Local sources who asked not to be identified have told the Boston Business Journal that the effort, dubbed “Project Tiger,” is expected to bring hundreds of new, senior-level executive and administrative jobs to the city. Those same sources also confirmed that the company in question is committed to Cambridge, versus other possible locations in Massachusetts, and has hired Transwestern|RBJ in Boston to find 150,000 to 200,000 square feet of office space, with the expectation of adding another 200,000 square feet of research and laboratory space once its primary move is complete. Transwestern|RBJ did not return calls for this story.
Based on an industry standard of around 200 square feet of space per employee, Project Tiger’s initial office requirement would be enough to house between 750 and 1,000 employees.
Local sources familiar with Project Tiger’s real estate needs say Cambridge’s tight office market will make it challenging to accommodate such a large demand for contiguous space. But options do exist, including:
--2 Canal Park, an empty 230,831-square-foot building owned by a real estate affiliate of TA Associates in Boston. The space recently saw around 40,000 square feet leased by Kayak.com, but still is mostly available for lease.
--88 Sidney St., a 145,000-square-foot building owned by MIT and recently vacated by Vertex Pharmaceuticals.
--35 and 200 Cambridgepark Drive, a complex of roughly 300,000 square feet of space being vacated and sold by Pfizer to King Street Properties, which could easily convert the properties to office space.
--Alexandria Center, a seven-building development in Kendall Square that is slated to include a 386,000-square-foot space for Ariad Pharmaceuticals. The company’s recent challenges have raised speculation that a pull-out from the project at 225 Binney St. is pending.
--50 Hampshire St., a 170,000-square-foot building owned by Biomed Realty Trust that is now home to CDM Smith Inc. The engineering and construction services firm has long been rumored to want a cheaper space, and Biomed is more likely to end its long-term lease with CDM if it can be replaced with a market-rate tenant in the life sciences industry.
No one knows for sure. During an interview with NECN, BBJ Managing Editor Craig Douglas said he’s heard from several sources the group may involve German pharmaceuticals giant Bayer AG, but that is not confirmed.
Earlier this month, Bayer made waves in the market when it sold a division to Boston Scientific for $415 million. According to the Boston Globe, the division makes a product used to remove blood clots.
The BBJ lists several potential Cambridge locations for Project Tiger, and promises more details in a Friday story.
So I totally think that works for what the architects were going for but that doesn't mean I like the building.
So I totally think that works for what the architects were going for but that doesn't mean I like the building.
I wouldn't have an issue with this building if it weren't so damn visible. It might be the most prominent building in Cambridge from the river, and that really demanded something more than a shrugging "kay, I guess we'll do something weird" from the design team.